Bristol-Myers Squibb Stock - Q2 2026 earnings date set for July 30
Published on 06/18/2026 at 21:22 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS
Edited by ad hoc news Earnings & Calendar Desk. Verified prior to publication on 06/18/2026, 21:21 UTC. Details in the imprint.
Bristol-Myers Squibb (US1078421011) has fixed the date for its next quarterly update. According to an IR release dated 06/18/2026, the company will report second-quarter 2026 results on 07/30/2026, followed by an investor call at 8:15 a.m. ET.
All news and key data on Bristol-Myers Squibb stock
Stay on top of Bristol-Myers Squibb with the latest company announcements, stock data and background on upcoming earnings dates.
Details of the Q2 earnings schedule
The Business Wire notice confirms that Bristol-Myers Squibb will publish its second-quarter 2026 figures before the opening of U.S. markets on Thursday, 07/30/2026, and host a conference call at 8:15 a.m. ET for analysts and investors.
The company typically provides a live audio webcast and a replay via its investor relations site, giving investors access to management’s commentary on sales trends, margins and pipeline milestones.
What to watch in the upcoming quarter
With the date now set, attention turns to what the second quarter might reveal about Bristol-Myers Squibb’s revenue mix between oncology, immunology and cardiovascular therapies, as well as the trajectory of key loss-of-exclusivity exposures.
Investors will also look closely at cash generation and capital allocation, including ongoing dividend payments and any signals on share repurchases or bolt-on deals in the company’s event calendar.
How Bristol-Myers Squibb makes its money
Bristol-Myers Squibb generates most of its revenue from branded prescription medicines in oncology, hematology, immunology and cardiovascular disease, including widely used therapies such as Eliquis for stroke prevention and several cancer treatments across solid tumors and hematologic malignancies.
Where the stock trades today
The shares of Bristol-Myers Squibb (US1078421011) trade on the New York Stock Exchange under the ticker BMY at around $40.00 as of 06/18/2026, 11:30 ET.
Key facts on Bristol-Myers Squibb stock
- Company: Bristol-Myers Squibb Company
- ISIN: US1078421011
- WKN: 850501
- Ticker: BMY
- Venue: New York Stock Exchange
- Price (as of 06/18/2026, 11:30 ET): 40.00 USD
- Market cap: 81,000,000,000 USD (as of 06/18/2026)
- Sector / Industry: Health Care / Pharmaceuticals
- Index membership: S&P 500
- Next earnings date: 07/30/2026
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
